Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Certain drugs that block specific enzymes can help treat prostate diseases.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Large prostate links to more hair loss, but age of onset doesn't affect it.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Suppressing certain hormones might help prevent prostate cancer.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

All treatments helped with prostate symptoms, but the combination of dibenyline and finasteride worked best without extra side effects.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Low-dose bisphenol A increases prostate size in rats by affecting certain enzymes.

Corn silk extract helps reduce prostate enlargement symptoms.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.